These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21278247)

  • 1. Genomic and epigenomic integration identifies a prognostic signature in colon cancer.
    Yi JM; Dhir M; Van Neste L; Downing SR; Jeschke J; Glöckner SC; de Freitas Calmon M; Hooker CM; Funes JM; Boshoff C; Smits KM; van Engeland M; Weijenberg MP; Iacobuzio-Donahue CA; Herman JG; Schuebel KE; Baylin SB; Ahuja N
    Clin Cancer Res; 2011 Mar; 17(6):1535-45. PubMed ID: 21278247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
    Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
    PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A methylation-driven gene panel predicts survival in patients with colon cancer.
    Peng Y; Zhao J; Yin F; Sharen G; Wu Q; Chen Q; Sun X; Yang J; Wang H; Zhang D
    FEBS Open Bio; 2021 Sep; 11(9):2490-2506. PubMed ID: 34184409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients.
    Ghatak S; Satapathy SR; Sjölander A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation based biomarkers in colorectal cancer: A systematic review.
    Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
    Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the utility of
    Nakasone ES; Zemla TJ; Yu M; Lin SY; Ou FS; Carter K; Innocenti F; Saltz L; Grady WM; Cohen SA
    Epigenetics; 2024 Dec; 19(1):2349980. PubMed ID: 38716804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
    Kim YH; Lee HC; Kim SY; Yeom YI; Ryu KJ; Min BH; Kim DH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim HC; Chun HK; Grady WM; Kim YS
    Ann Surg Oncol; 2011 Aug; 18(8):2338-47. PubMed ID: 21298349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
    Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
    Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
    Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study.
    Kuan JC; Wu CC; Sun CA; Chu CM; Lin FG; Hsu CH; Kan PC; Lin SC; Yang T; Chou YC
    PLoS One; 2015; 10(3):e0123396. PubMed ID: 25815725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
    Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
    Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
    Yokoi K; Harada H; Yokota K; Ishii S; Tanaka T; Nishizawa N; Shimazu M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Feb; 26(2):406-414. PubMed ID: 30311169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
    Semaan A; Uhl B; Branchi V; Lingohr P; Bootz F; Kristiansen G; Kalff JC; Matthaei H; Pantelis D; Dietrich D
    Clin Colorectal Cancer; 2018 Jun; 17(2):e385-e393. PubMed ID: 29580650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale external validation and meta-analysis of gene methylation biomarkers in tumor tissue for colorectal cancer prognosis.
    Yuan T; Wankhede D; Edelmann D; Kather JN; Tagscherer KE; Roth W; Bewerunge-Hudler M; Brobeil A; Kloor M; Bläker H; Brenner H; Hoffmeister M
    EBioMedicine; 2024 Jul; 105():105223. PubMed ID: 38917511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer.
    Chen Z; Huang Z; Luo Y; Zou Q; Bai L; Tang G; Wang X; Cao G; Huang M; Xiang J; Yu H
    J Transl Med; 2021 Feb; 19(1):73. PubMed ID: 33593392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma.
    Kumar A; Singh P; Pandey A; Gosipatala SB
    Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.